Copyright
©The Author(s) 2020.
World J Gastroenterol. Apr 21, 2020; 26(15): 1733-1744
Published online Apr 21, 2020. doi: 10.3748/wjg.v26.i15.1733
Published online Apr 21, 2020. doi: 10.3748/wjg.v26.i15.1733
Ref. | Country/ Region | X-line | Publication year | Drug combination (per day) | Duration (d) | Eradication rate (%) | |
ITT | PP | ||||||
Wong et al[36] | China | 2nd and more | 2003 | LVFX 500 mg + RBT 300 mg + RPZ 40 mg | 7 | 91.1 | 91.1 |
Zullo et al[37] | Italy | 3rd | 2003 | LVFX 500 mg + AMX 2000 mg + RPZ 40 mg | 10 | 83.3 | 88.2 |
Nista et al[38] | Italy | 2nd | 2003 | LVFX 500 mg + AMX 2000 mg + RPZ 40 mg | 10 | 94.3 | 94.3 |
Perri et al[39] | Italy | 2nd | 2003 | LVFX 500 mg + AMX 2000 mg + PPZ 80 mg | 7 | 63.8 | 66.1 |
Watanabe et al[40] | Japan | 2nd | 2003 | LVFX 400 mg + AMX 2000 mg + LPZ 60 mg | 7 | 69.7 | 69.7 |
Bilardi et al[41] | Italy | 2nd and more | 2004 | LVFX 500 mg + AMX 2000 mg + PPZ 80 mg | 10 | 70.5 | 75.6 |
Matsumoto et al[42] | Japan | 2nd | 2005 | LVFX 600 mg + AMX 2000 mg + LPZ 60 mg | 7 | 70.0 | 72.4 |
Wong et al[43] | China | 2nd and more | 2006 | LVFX 1000 mg + AMX 2000 mg + LPZ 60 mg | 7 | 57.4 | 59.6 |
Gisbert et al[44] | Spain | 3rd | 2006 | LVFX 1000 mg + AMX 2000 mg + OPZ 40 mg | 10 | 60.0 | 66.3 |
Perna et al[45] | Italy | 2nd | 2007 | LVFX 500 mg + AMX 2000 mg + RPZ 40 mg | 10 | 72.7 | 72.7 |
Gisbert et al[46] | Spain | 2nd | 2008 | LVFX 1000 mg + AMX 2000 mg + OPZ 40 mg | 10 | 77.3 | 81.4 |
Di Caro et al[47] | Italy | 2nd | 2009 | LVFX 500 mg + AMX 2000 mg + EPZ 40 mg | 7 | 65.0 | 65.0 |
Di Caro et al[47] | Italy | 2nd | 2009 | LVFX 1000 mg + AMX 2000 mg + EPZ 40 mg | 7 | 70.0 | 70.0 |
Di Caro et al[47] | Italy | 2nd | 2009 | LVFX 500 mg + AMX 2000 mg + EPZ 40 mg | 10 | 90.0 | 90.0 |
Di Caro et al[47] | Italy | 2nd | 2009 | LVFX 1000 mg + AMX 2000 mg + EPZ 40 mg | 10 | 85.0 | 85.0 |
Liou et al[48] | Taiwan | 2nd | 2010 | LVFX 750 mg + AMX 2000 mg + LPZ 60 mg | 7 | 76.9 | 80.0 |
Liou et al[49] | Taiwan | 2nd | 2011 | Modified sequential regimen1 | 10 | 95.1 | 96.4 |
Hu et al[50] | Taiwan | 2nd | 2011 | LVFX 500 mg + AMX 2000 mg + EPZ 80 mg | 7 | 68.9 | 75.6 |
Ermis et al[51] | Turkey | 2nd | 2011 | LVFX 1000 mg + AMX 2000 mg + LPZ 60 mg | 7 | 37.8 | 41.2 |
Goh et al[52] | Malaysia | 2nd | 2012 | LVFX 1000 mg + AMX 2000 mg + RPZ 40 mg | 14 | 90.3 | 90.3 |
Chuah et al[53] | Taiwan | 2nd | 2012 | LVFX 500 mg + AMX 2000 mg + EPZ 80 mg | 7 | 78.1 | 80.3 |
Gisbert et al[54] | Spain | 2nd | 2013 | LVFX 1000 mg + AMX 2000 mg + OPZ 40 mg | 10 | 73.8 | 75.1 |
Calhan et al[55] | Turkey | 2nd | 2013 | Modified sequential regimen2 | 12 | 82.2 | 85.7 |
Calhan et al[55] | Turkey | 2nd | 2013 | LVFX 500 mg + TET 2000 mg + PPZ 80 mg + bismuth 1200 mg | 10 | 90.6 | 93.1 |
Moon et al[56] | South Korea | 2nd | 2013 | LVFX 500 mg + MTZ 1500 mg + LPZ 60 mg | 7 | 67.9 | 73.1 |
Tai et al[57] | Taiwan | 2nd | 2013 | LVFX 500 mg + AMX 2000 mg + EPZ 80 mg | 10 | 68.0 | 75.6 |
Tai et al[57] | Taiwan | 2nd | 2013 | LVFX 500 mg + AMX 2000 mg + EPZ 80 mg | 14 | 86.0 | 92.5 |
Murakami et al[58] | Japan | 3rd | 2013 | LVFX 500 mg + AMX 1500 mg + LPZ 60 mg | 7 | 43.1 | 43.7 |
Gisbert et al[59] | Spain | 2nd | 2015 | LVFX 500 mg + AMX 2000 mg + EPZ 80 mg + bismuth 480 mg | 14 | 90.0 | 91.1 |
Cao et al[60] | China | 2nd | 2015 | LVFX 500 mg + AMX 2000 mg + LPZ 60 mg + bismuth 480 mg | 14 | 83.0 | 85.4 |
Paoluzi et al[61] | Italy | 3rd | 2015 | LVFX 1000 mg + DOXY 200 mg + EPZ 40 mg | 7 | 46.0 | 49.0 |
Liou et al[62] | Taiwan | 2nd | 2016 | LVFX 500 mg + AMX 2000 mg + LPZ 60 mg | 10 | 75.3 | 78.8 |
Liou et al[62] | Taiwan | 2nd | 2016 | Modified sequential regimen3 | 10 | 84.3 | 86.3 |
Song et al[63] | China | 2nd | 2016 | LVFX 500 mg + AMX 2000 mg + EPZ 40 mg + bismuth 440 mg | 14 | 73.5 | 78.5 |
Hsu et al[64] | Taiwan | 2nd | 2017 | LVFX 500 mg + TET 2000 mg + EPZ 80 mg + bismuth 480 mg | 10 | 98.0 | 97.8 |
Hsu et al[64] | Taiwan | 2nd | 2017 | LVFX 500 mg + AMX 2000 mg + EPZ 80 mg | 10 | 69.2 | 68.6 |
- Citation: Mori H, Suzuki H. Update on quinolone-containing rescue therapies for Helicobacter pylori infection. World J Gastroenterol 2020; 26(15): 1733-1744
- URL: https://www.wjgnet.com/1007-9327/full/v26/i15/1733.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i15.1733